Skip to main content


Annals of Nuclear Medicine

Annals of Nuclear Medicine OnlineFirst articles

22.11.2020 | Original Article

Absorbed dose simulation of meta-211At-astato-benzylguanidine using pharmacokinetics of 131I-MIBG and a novel dose conversion method, RAP

Radionuclides emit various ionizing radiations depending on the different types of radioactive decay and provide many benefits in nuclear medicine therapy and diagnosis. Radiohalogens have been used in nuclear medicine. The beta particles emitted …

12.11.2020 | Original Article

Performance assessment of the ALBIRA II pre-clinical SPECT S102 system for 99mTc imaging

Quantitative imaging with a pre-clinical single-photon emission computed tomography (SPECT) is frequently used in research with small animal models such as mice and rats as part of the process for the development of diagnostic and therapeutic …

11.11.2020 | Short Communication Open Access

18F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma

CD19-targeted chimeric antigen receptor (CAR)-T-cell immunotherapy has shown remarkable efficacy in relapsed and/or refractory (r/r) CD19 + B-cell malignancies including diffuse large B-cell lymphoma (DLBCL) [ 1 ]. Of note, CAR-T cells expand in …

01.11.2020 | Original Article

131I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with 177Lu-DOTATATE peptide receptor radionuclide therapy

Paraganglioma (PGL) and pheochromocytoma (PCC) are rare neuroendocrine tumors (NETs) with incidence rate of 0.8/100,000 patients per year [ 1 ]. The treatment of choice for non-metastatic/localized PGL is a surgical resection of lesion, which can …

22.10.2020 | Original Article

The prognostic role of end-of-treatment FDG-PET/CT in diffuse large B cell lymphoma: a pilot study application of neural networks to predict time-to-event

In the era of personalized and precision medicine, strong predictive and prognostic tools are needed in the management of diffuse large B cell lymphoma (DLBCL), to accurately predict relapse of disease and to possibly improve treatment regimen …

Aktuelle Ausgaben

Über diese Zeitschrift

Annals of Nuclear Medicine is an official journal of the Japanese Society of Nuclear Medicine. It develops the appropriate application of radioactive substances and stable nuclides in the field of medicine.

The journal promotes the exchange of ideas and information and research in nuclear medicine and includes the medical application of radionuclides and related subjects. It presents original articles, short communications, reviews and letters to the editor.

Free Open Access Publication Program - Submit your paper to ANM for this privilege!

Open Access (OA) publication is a good way to expose your article to many readers in the world. ANM may offer authors with charge free OA publication for high-quality articles. Upon acceptance of articles, OA publication in this program is considered according to the recommendation from the editor who manages the particular manuscript, and the editor-in-chief makes a final decision. The authors are noticed in the letter of acceptance if their article is selected for this offer.

Weitere Informationen